Prostate cancer treatment tied to Alzheimer’s risk

09 Dec 2015


Androgen deprivation therapy used to treat prostate cancer is linked to a higher risk of developing Alzheimer's, according to a study in the Journal of Clinical Oncology.

New York Times


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story